Review

Published on 14 Apr 2023

The toxicity associated with combining immune check point inhibitors with tyrosine kinase inhibitors in patients with non-small cell lung cancer

in Thoracic Oncology

Anjali Kalra
Sawsan Rashdan

Frontiers in Oncology

doi 10.3389/fonc.2023.1158417

3,490 views
8 citations

Case Report

Published on 12 Apr 2023

Pulmonary blastoma treatment response to anti-PD-1 therapy: a rare case report and literature review

in Thoracic Oncology

Yalin Xie
Ning Su
Chaoxia Li
An Lei
Lei Li
Jianjun Zou
Wencang Cen
Jinxing Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1146204

1,610 views
3 citations

Original Research

Published on 12 Apr 2023

Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China

in Thoracic Oncology

Wenyu Yang
Tao Li
Yibing Bai
Yaping Long
Ming Gao
Ting Wang
Fangfang Jing
Fan Zhang
Haitao Tao
Junxun Ma

Frontiers in Oncology

doi 10.3389/fonc.2023.1147903

1,769 views
3 citations

Systematic Review

Published on 11 Apr 2023

Diagnostic value of combination of biomarkers for malignant pleural mesothelioma: a systematic review and meta-analysis

in Thoracic Oncology

Mucheng Zhu
Zhenhua Lu
Hao Guo
Xiaoting Gu
Defang Wei
Zhengyi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1136049

1,840 views
1 citation

Case Report

Published on 11 Apr 2023

Case report: anaplastic lymphoma kinase (ALK) rearranged adenocarcinoma with high level of microsatellite instability response to pembrolizumab

in Thoracic Oncology

Naoko Shigeta
Shuji Murakami
Tomoyuki Yokose
Yohei Miyagi
Haruhiro Saito

Frontiers in Oncology

doi 10.3389/fonc.2023.1110638

1,644 views
1 citation

Case Report

Published on 11 Apr 2023

Primary ectopic meningioma in the thoracic cavity: A rare case report and review of the literature

in Thoracic Oncology

Xu Liu
Jiao Liu
Ting Nai
Yuxia Yang
Yuchang Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1149627

1,795 views
2 citations

Case Report

Published on 06 Apr 2023

Long-term survival with anlotinib as a front-line treatment in an elderly NSCLC patient: A case report

in Thoracic Oncology

Jingyi Wang
Xiaoqing Li
Juan Zhou
Dan Qiu
Mengyao Zhang
Lan Sun
Shengwen Calvin Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1043244

1,436 views
2 citations

Original Research

Published on 05 Apr 2023

Primary lung cancer in children and adolescents: Analysis of a surveillance, epidemiology, and end results database

in Thoracic Oncology

Weipeng Shao
Jie Liu
Bobo Li
Xiaokang Guo
Jian Sun
Hui Li
Hongbo Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1053248

7,028 views
5 citations

Original Research

Published on 05 Apr 2023

Reconsidering the T category for the T3 non-small cell lung cancer with additional tumor nodules in the same lobe: A population-based study

in Thoracic Oncology

Jing-Sheng Cai
Fan Yang
Xun Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1043386

1,680 views
2 citations

Clinical Trial

Published on 04 Apr 2023

Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancer

in Thoracic Oncology

Josephine Louella Feliciano
Dylan McLoone
Yingxin Xu
Ruben G.W. Quek
Andreas Kuznik
Jean-Francois Pouliot
Giuseppe Gullo
Petra Rietschel
Patricia Guyot
Gerasimos Konidaris

Frontiers in Oncology

doi 10.3389/fonc.2022.1081729

3,876 views
2 citations

Methods

Published on 04 Apr 2023

Is cancer stage data missing completely at random? A report from a large population-based cohort of non-small cell lung cancer

in Thoracic Oncology

Andrew G. Robinson
Paul Nguyen
Catherine L. Goldie
Matthew Jalink
Timothy P. Hanna

Frontiers in Oncology

doi 10.3389/fonc.2023.1146053

4,528 views
1 citation

Original Research

Published on 03 Apr 2023

Combined systemic immune-inflammatory index and prognostic nutritional index predict outcomes in advanced non-small cell lung cancer patients receiving platinum-doublet chemotherapy

in Thoracic Oncology

Ruiyun Fan
Ying Chen
Guopeng Xu
Wen Pan
Yantian Lv
Zhongwei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.996312

2,447 views
6 citations

Original Research

Published on 31 Mar 2023

Ultra-rapid Idylla™ EGFR mutation screening followed by next-generation sequencing: An integrated solution to molecular diagnosis of non-small cell lung cancer

in Thoracic Oncology

Tian Qiu
Fanshuang Zhang
Bo Zheng
Zitong Feng
Weihua Li
Hua Zeng
Lixia Chu
Jianming Ying

Frontiers in Oncology

doi 10.3389/fonc.2023.1064487

2,704 views
1 citation

Case Report

Published on 31 Mar 2023

Case report: Primary pleural giant extraskeletal Ewing sarcoma in a child

in Thoracic Oncology

Yang Wu
Chao-Bang Xie
Qiong Huang
Kai-Fei Zhao

Frontiers in Oncology

doi 10.3389/fonc.2023.1137586

1,726 views
3 citations

Original Research

Published on 30 Mar 2023

Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study

in Thoracic Oncology

Kailun Fei
Gang Guo
Jie Wang
Zhijie Wang
Yan Wang
Xuezhi Hao
Jia Zhong
Qinxiang Guo
Wei Guo
Wenzhong Su

Frontiers in Oncology

doi 10.3389/fonc.2023.1145303

2,079 views
2 citations

Original Research

Published on 28 Mar 2023

Surgical selection and regional lymph node dissection for stage I second primary lung cancer patients following surgery for stage I first primary lung cancer

in Thoracic Oncology

Xiao Wu
Youhua Jiang
Qixun Chen
Jiangfeng Wang
Jianqiang Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1148422

1,053 views

Navigation group

Articles

The toxicity associated with combining immune check point inhibitors with tyrosine kinase inhibitors in patients with non-small cell lung cancer

Pulmonary blastoma treatment response to anti-PD-1 therapy: a rare case report and literature review

Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China

Diagnostic value of combination of biomarkers for malignant pleural mesothelioma: a systematic review and meta-analysis

Case report: anaplastic lymphoma kinase (ALK) rearranged adenocarcinoma with high level of microsatellite instability response to pembrolizumab

Primary ectopic meningioma in the thoracic cavity: A rare case report and review of the literature

Long-term survival with anlotinib as a front-line treatment in an elderly NSCLC patient: A case report

Primary lung cancer in children and adolescents: Analysis of a surveillance, epidemiology, and end results database

Reconsidering the T category for the T3 non-small cell lung cancer with additional tumor nodules in the same lobe: A population-based study

Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancer

Is cancer stage data missing completely at random? A report from a large population-based cohort of non-small cell lung cancer

Combined systemic immune-inflammatory index and prognostic nutritional index predict outcomes in advanced non-small cell lung cancer patients receiving platinum-doublet chemotherapy

Ultra-rapid Idylla™ EGFR mutation screening followed by next-generation sequencing: An integrated solution to molecular diagnosis of non-small cell lung cancer

Case report: Primary pleural giant extraskeletal Ewing sarcoma in a child

Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study

Surgical selection and regional lymph node dissection for stage I second primary lung cancer patients following surgery for stage I first primary lung cancer